Selected research
Industry Growth & Trends
Global Prenatal Screening Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Prenatal Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Prenatal Screening is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Prenatal Screening is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Prenatal Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Prenatal Screening market include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB and Veritas Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Prenatal Screening market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Prenatal Screening market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prenatal Screening market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prenatal Screening.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Prenatal Screening market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Prenatal Screening Market by Company
Thermo Fisher Scientific
Revvity
Quest Diagnostics
MedGenome
Mayo Clinic Laboratories
GeneDx
PreventionGenetics
SYNLAB
Veritas Genetics
GGA
Cordlife
Rainbow Genomics
BGI Genomics
Berry Genomics
Annaroad
Jiajian Medical Testing
Genesky
Weihansi Biomedical Technology
Prenatal Screening Segment by Type
Serum Biomarker Screening
Ultrasonographic Imaging Screening
Others
Prenatal Screening Segment by Application
Public Hospitals
Private Hospitals
Prenatal Screening Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prenatal Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Screening.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Prenatal Screening companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Serum Biomarker Screening
- Ultrasonographic Imaging Screening
- Others
Applications
- Public Hospitals
- Private Hospitals
Companies covered
- Thermo Fisher Scientific
- Revvity
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- GeneDx
- PreventionGenetics
- SYNLAB
- Veritas Genetics
- GGA
- Cordlife
- Rainbow Genomics
- BGI Genomics
- Berry Genomics
- Annaroad
- Jiajian Medical Testing
- Genesky
- Weihansi Biomedical Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Prenatal Screening Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Prenatal Screening Market Size by Region (2021-2032)
- 1.4.1 Global Prenatal Screening Market Size by Region (2021-2026)
- 1.4.2 Global Prenatal Screening Market Size by Region (2027-2032)
- 1.5 Key Regions Prenatal Screening Market Size (2021-2032)
- 1.5.1 North America Prenatal Screening Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Prenatal Screening Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Prenatal Screening Market Size Growth Rate (2021-2032)
- 1.5.4 South America Prenatal Screening Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Prenatal Screening Market Size Growth Rate (2021-2032)
2 Prenatal Screening Market by Type
- 2.1 Type Introduction
- 2.1.1 Serum Biomarker Screening
- 2.1.2 Ultrasonographic Imaging Screening
- 2.1.3 Others
- 2.2 Global Prenatal Screening Market Size by Type
- 2.2.1 Global Prenatal Screening Market Size Overview by Type (2021-2032)
- 2.2.2 Global Prenatal Screening Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Prenatal Screening Market Size Forecasted by Type (2027-2032)
- 2.3 Global Prenatal Screening Market Size by Regions
- 2.3.1 North America Prenatal Screening Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Prenatal Screening Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Prenatal Screening Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Prenatal Screening Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Prenatal Screening Market Size Breakdown by Type (2021-2026)
3 Prenatal Screening Market by Application
- 3.1 Type Introduction
- 3.1.1 Public Hospitals
- 3.1.2 Private Hospitals
- 3.2 Global Prenatal Screening Market Size by Application
- 3.2.1 Global Prenatal Screening Market Size Overview by Application (2021-2032)
- 3.2.2 Global Prenatal Screening Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Prenatal Screening Market Size Forecasted by Application (2027-2032)
- 3.3 Global Prenatal Screening Market Size by Regions
- 3.3.1 North America Prenatal Screening Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Prenatal Screening Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Prenatal Screening Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Prenatal Screening Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Prenatal Screening Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Prenatal Screening Industry Trends
- 4.2 Prenatal Screening Industry Drivers
- 4.3 Prenatal Screening Industry Opportunities and Challenges
- 4.4 Prenatal Screening Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Prenatal Screening Revenue (2021-2026)
- 5.2 Global Prenatal Screening Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Prenatal Screening Key Company Headquarters & Area Served
- 5.4 Global Prenatal Screening Company, Product Type & Application
- 5.5 Global Prenatal Screening Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Prenatal Screening Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Prenatal Screening Players Market Share by Revenue in 2025
- 5.6.3 2025 Prenatal Screening Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Prenatal Screening Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Revvity
- 6.2.1 Revvity Company Information
- 6.2.2 Revvity Business Overview
- 6.2.3 Revvity Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Revvity Prenatal Screening Product Portfolio
- 6.2.5 Revvity Recent Developments
- 6.3 Quest Diagnostics
- 6.3.1 Quest Diagnostics Company Information
- 6.3.2 Quest Diagnostics Business Overview
- 6.3.3 Quest Diagnostics Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Quest Diagnostics Prenatal Screening Product Portfolio
- 6.3.5 Quest Diagnostics Recent Developments
- 6.4 MedGenome
- 6.4.1 MedGenome Company Information
- 6.4.2 MedGenome Business Overview
- 6.4.3 MedGenome Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 MedGenome Prenatal Screening Product Portfolio
- 6.4.5 MedGenome Recent Developments
- 6.5 Mayo Clinic Laboratories
- 6.5.1 Mayo Clinic Laboratories Company Information
- 6.5.2 Mayo Clinic Laboratories Business Overview
- 6.5.3 Mayo Clinic Laboratories Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Mayo Clinic Laboratories Prenatal Screening Product Portfolio
- 6.5.5 Mayo Clinic Laboratories Recent Developments
- 6.6 GeneDx
- 6.6.1 GeneDx Company Information
- 6.6.2 GeneDx Business Overview
- 6.6.3 GeneDx Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 GeneDx Prenatal Screening Product Portfolio
- 6.6.5 GeneDx Recent Developments
- 6.7 PreventionGenetics
- 6.7.1 PreventionGenetics Company Information
- 6.7.2 PreventionGenetics Business Overview
- 6.7.3 PreventionGenetics Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 PreventionGenetics Prenatal Screening Product Portfolio
- 6.7.5 PreventionGenetics Recent Developments
- 6.8 SYNLAB
- 6.8.1 SYNLAB Company Information
- 6.8.2 SYNLAB Business Overview
- 6.8.3 SYNLAB Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 SYNLAB Prenatal Screening Product Portfolio
- 6.8.5 SYNLAB Recent Developments
- 6.9 Veritas Genetics
- 6.9.1 Veritas Genetics Company Information
- 6.9.2 Veritas Genetics Business Overview
- 6.9.3 Veritas Genetics Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Veritas Genetics Prenatal Screening Product Portfolio
- 6.9.5 Veritas Genetics Recent Developments
- 6.10 GGA
- 6.10.1 GGA Company Information
- 6.10.2 GGA Business Overview
- 6.10.3 GGA Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 GGA Prenatal Screening Product Portfolio
- 6.10.5 GGA Recent Developments
- 6.11 Cordlife
- 6.11.1 Cordlife Company Information
- 6.11.2 Cordlife Business Overview
- 6.11.3 Cordlife Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Cordlife Prenatal Screening Product Portfolio
- 6.11.5 Cordlife Recent Developments
- 6.12 Rainbow Genomics
- 6.12.1 Rainbow Genomics Company Information
- 6.12.2 Rainbow Genomics Business Overview
- 6.12.3 Rainbow Genomics Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Rainbow Genomics Prenatal Screening Product Portfolio
- 6.12.5 Rainbow Genomics Recent Developments
- 6.13 BGI Genomics
- 6.13.1 BGI Genomics Company Information
- 6.13.2 BGI Genomics Business Overview
- 6.13.3 BGI Genomics Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 BGI Genomics Prenatal Screening Product Portfolio
- 6.13.5 BGI Genomics Recent Developments
- 6.14 Berry Genomics
- 6.14.1 Berry Genomics Company Information
- 6.14.2 Berry Genomics Business Overview
- 6.14.3 Berry Genomics Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Berry Genomics Prenatal Screening Product Portfolio
- 6.14.5 Berry Genomics Recent Developments
- 6.15 Annaroad
- 6.15.1 Annaroad Company Information
- 6.15.2 Annaroad Business Overview
- 6.15.3 Annaroad Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Annaroad Prenatal Screening Product Portfolio
- 6.15.5 Annaroad Recent Developments
- 6.16 Jiajian Medical Testing
- 6.16.1 Jiajian Medical Testing Company Information
- 6.16.2 Jiajian Medical Testing Business Overview
- 6.16.3 Jiajian Medical Testing Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Jiajian Medical Testing Prenatal Screening Product Portfolio
- 6.16.5 Jiajian Medical Testing Recent Developments
- 6.17 Genesky
- 6.17.1 Genesky Company Information
- 6.17.2 Genesky Business Overview
- 6.17.3 Genesky Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Genesky Prenatal Screening Product Portfolio
- 6.17.5 Genesky Recent Developments
- 6.18 Weihansi Biomedical Technology
- 6.18.1 Weihansi Biomedical Technology Company Information
- 6.18.2 Weihansi Biomedical Technology Business Overview
- 6.18.3 Weihansi Biomedical Technology Prenatal Screening Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Weihansi Biomedical Technology Prenatal Screening Product Portfolio
- 6.18.5 Weihansi Biomedical Technology Recent Developments
7 North America
- 7.1 North America Prenatal Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Prenatal Screening Market Size by Country (2021-2026)
- 7.3 North America Prenatal Screening Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Prenatal Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Prenatal Screening Market Size by Country (2021-2026)
- 8.3 Europe Prenatal Screening Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Prenatal Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Prenatal Screening Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Prenatal Screening Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Prenatal Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Prenatal Screening Market Size by Country (2021-2026)
- 10.3 South America Prenatal Screening Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Prenatal Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Prenatal Screening Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Prenatal Screening Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst